Solara Active Pharma Sciences Limited (BOM:890202)
India
· Delayed Price · Currency is INR 273.00
+12.75 (4.90%)
At close: Apr 3, 2025
BOM:890202 Statistics
Total Valuation
BOM:890202 has a market cap or net worth of INR 25.67 billion. The enterprise value is 34.03 billion.
| Market Cap | 25.67B |
| Enterprise Value | 34.03B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -28.14% |
| Shares Change (QoQ) | +26.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 32.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.96 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 3.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.47 |
| EV / Sales | 2.60 |
| EV / EBITDA | 20.10 |
| EV / EBIT | 47.64 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 4.96 |
| Debt / FCF | n/a |
| Interest Coverage | 0.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.04% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.08M |
| Profits Per Employee | -1.17M |
| Employee Count | 2,156 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 270.90 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.16 |
| Average Volume (20 Days) | 405 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:890202 had revenue of INR 13.10 billion and -2.53 billion in losses. Loss per share was -97.95.
| Revenue | 13.10B |
| Gross Profit | 5.84B |
| Operating Income | 714.40M |
| Pretax Income | -1.64B |
| Net Income | -2.53B |
| EBITDA | 1.68B |
| EBIT | 714.40M |
| Loss Per Share | -97.95 |
Balance Sheet
The company has 60.70 million in cash and 8.40 billion in debt, giving a net cash position of -8.34 billion.
| Cash & Cash Equivalents | 60.70M |
| Total Debt | 8.40B |
| Net Cash | -8.34B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 10.89B |
| Book Value Per Share | 344.38 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.58%, with operating and profit margins of 5.45% and -19.29%.
| Gross Margin | 44.58% |
| Operating Margin | 5.45% |
| Pretax Margin | -12.52% |
| Profit Margin | -19.29% |
| EBITDA Margin | 12.80% |
| EBIT Margin | 5.45% |
| FCF Margin | n/a |
Dividends & Yields
BOM:890202 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 28.14% |
| Shareholder Yield | 28.14% |
| Earnings Yield | -9.85% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |